Abstract
Summary
Japanese postmenopausal women with symptomatic periodontal disease had a significantly smaller increase in the T-score for total hip bone density than those without periodontal disease during medication therapy for osteoporosis. Intervention to treat symptomatic periodontal disease before and/or during osteoporosis therapy could maintain the effect of osteoporosis medications.
Purpose
Women with periodontal disease may be more likely to develop osteoporosis. We evaluated whether the presence of symptomatic periodontal disease can influence changes in skeletal bone mineral density (BMD) during medication therapy for osteoporosis in Japanese postmenopausal women.
Methods
A total of 4,258 postmenopausal women participated in the Japanese Osteoporosis Intervention Trial protocol number 4 (JOINT-04 trial) and number 5 (JOINT-05 trial), which were multi-center, open-label, randomized controlled trials in Japan. Of these, 3,670 non-edentulous subjects participated in the study. Subjects who had self-reported symptoms of periodontal disease at baseline were defined as having periodontal disease. The study outcome was the difference in BMD changes during the study between subjects with and without periodontal disease. Mixed models for repeated measures after adjusting for covariates were used to investigate the difference in the BMD changes during the study between subjects with and without periodontal disease.
Results
Subjects with periodontal disease had significantly lower T-scores for total hip (p = 0.035) and metacarpal (p = 0.048) BMD than those without periodontal disease at baseline. During medication therapy for osteoporosis, subjects with periodontal disease had a significantly smaller increase in T-score for total hip BMD than those without periodontal disease (p = 0.021), although no significant differences were observed in the changes in T-scores for other skeletal BMD measurements between subjects with and without periodontal disease.
Conclusions
The presence of self-reported symptoms of periodontal disease may be associated with a decrease in the effect of osteoporosis medications in Japanese postmenopausal women.
Similar content being viewed by others
Data availability
Not applicable.
Code availability
Not applicable.
References
Tonetti MS, Greenwell H, Kornman KS (2018) Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Clin Periodontol 45(Suppl 20):S149–S161. https://doi.org/10.1111/jcpe.12945
Ministry of Health, Labour and Welfare (2017) Survey of dental diseases. https://www.mhlw.go.jp/toukei/list/62-28.html. Accessed 2 June 2017
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1211–1259. https://doi.org/10.1016/S0140-6736(17)32154-2
Jin L, Lamster I, Greenspan J, Pitts N, Scully C, Warnakulasuriya S (2016) Global burden of oral diseases: emerging concepts, management and interplay with systemic health. Oral Dis 22:609–619. https://doi.org/10.1111/odi.12428
Tonetti MS, Bottenberg P, Conrads G, Eickholz P, Heasman P, Huysmans MC, López R, Madianos P, Müller F, Needleman I, Nyvad B, Preshaw PM, Pretty I, Renvert S, Schwendicke F, Trombelli L, van der Putten GJ, Vanobbergen J, West N, Young A, Paris S (2017) Dental caries and periodontal diseases in the ageing population: call to action to protect and enhance oral health and well-being as an essential component of healthy ageing - Consensus report of group 4 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J Clin Periodontol 44(Suppl 18):S135–S144. https://doi.org/10.1111/jcpe.12681
Krall EA, Dawson-Hughes B, Papas A, Garcia RI (1994) Tooth loss and skeletal bone density in healthy postmenopausal women. Osteoporos Int 4:104–109. https://doi.org/10.1007/BF01623233
Krall EA, Garcia RI, Dawson-Hughes B (1996) Increased risk of tooth loss is related to bone loss at the whole body, hip, and spine. Calcif Tissue Int 59:433–437. https://doi.org/10.1007/BF00369206
Penoni DC, Fidalgo TK, Torres SR, Varela VM, Masterson D, Leão AT, Maia LC (2017) Bone density and clinical periodontal attachment in postmenopausal women: a systematic review and meta-analysis. J Dent Res 96:261–269. https://doi.org/10.1177/0022034516682017
Goyal L, Goyal T, Gupta ND (2017) Osteoporosis and periodontitis in postmenopausal women: a systematic review. J Midlife Health 8:151–158. https://doi.org/10.4103/jmh.JMH_55_17
Xu S, Zhang G, Guo JF, Tan YH (2021) Associations between osteoporosis and risk of periodontitis: a pooled analysis of observational studies. Oral Dis 27:357–369. https://doi.org/10.1111/odi.13531
Penoni DC, Leão ATT, Torres SR, Farias MLF, Fernandes TM, Crivelli M, Vettore MV (2018) Effects of bone fragility and antiresorptive drugs on periodontal disease and tooth loss: a longitudinal study. JDR Clin Trans Res 3:378–387. https://doi.org/10.1177/2380084418787451
Taguchi A, Shiraki M, Tanaka S, Ohshige H, Nakamura T (2019) Improved periodontal disease and prevention of tooth loss in osteoporosis patients receiving once-yearly zoledronic acid: a randomized clinical trial. Menopause 26:1277–1283. https://doi.org/10.1097/GME.0000000000001393
Mau LP, Kuan YC, Tsai YC, Lin JJ, Huynh-Ba G, Weng PW, Shieh YS, Cheng WC, Huang RY (2017) Patients with chronic periodontitis present increased risk for osteoporosis: a population-based cohort study in Taiwan. J Periodontal Res 52:922–929. https://doi.org/10.1111/jre.12464
Choi JK, Kim YT, Kweon HI, Park EC, Choi SH, Lee JH (2017) Effect of periodontitis on the development of osteoporosis: results from a nationwide population-based cohort study (2003–2013). BMC Womens Health 17:77. https://doi.org/10.1186/s12905-017-0440-9
Larvin H, Kang J, Aggarwal VR, Pavitt S, Wu J (2021) Risk of incident cardiovascular disease in people with periodontal disease: a systematic review and meta-analysis. Clin Exp Dent Res 7:109–122. https://doi.org/10.1002/cre2.336
Wu CZ, Yuan YH, Liu HH, Li SS, Zhang BW, Chen W, An ZJ, Chen SY, Wu YZ, Han B, Li CJ, Li LJ (2020) Epidemiologic relationship between periodontitis and type 2 diabetes mellitus. BMC Oral Health 20:204. https://doi.org/10.1186/s12903-020-01180-w
Gomes-Filho IS, Cruz SSD, Trindade SC, Passos-Soares JS, Carvalho-Filho PC, Figueiredo ACMG, Lyrio AO, Hintz AM, Pereira MG, Scannapieco F (2020) Periodontitis and respiratory diseases: a systematic review with meta-analysis. Oral Dis 26:439–446. https://doi.org/10.1111/odi.13228
Michaud DS, Fu Z, Shi J, Chung M (2017) Periodontal disease, tooth loss, and cancer risk. Epidemiol Rev 39:49–58. https://doi.org/10.1093/epirev/mxx006
Uemura Y, Tanaka S, Miyazaki T, Tsukiyama M, Sone T, Taguchi A, Soen S, Mori S, Hagino H, Sugimoto T, Fukunaga M, Ohta H, Nakamura T, Orimo H, Shiraki M, Adequate Treatment of Osteoporosis (A-TOP) Research Group (2019) Study design of multi-center, open-label randomized controlled, head-to-head trial comparing minodronic acid and raloxifene: Japanese Osteoporosis Intervention Trial (JOINT)-04. J Bone Miner Metab 37:491–495. https://doi.org/10.1007/s00774-018-0942-z
Tanaka S, Mori S, Hagino H, Sugimoto T (2020) Design of a randomized trial of teriparatide followed by alendronate: Japanese Osteoporosis Intervention Trial-05 (JOINT-05). J Bone Miner Metab 38:412–417. https://doi.org/10.1007/s00774-019-01074-0
Taguchi A, Uemura Y, Imai T, Tanaka S, Ohta H, Nakamura T, Orimo H, Sugimoto T, Soen S, Shiraki M, Adequate Treatment of Osteoporosis (A-TOP) Research Group (2019) Incidence of osteonecrosis of the jaw in Japanese osteoporosis patients taking minodronic acid. J Bone Miner Metab 37:886–892. https://doi.org/10.1007/s00774-019-00990-5
Taguchi A, Suei Y, Ohtsuka M, Nakamoto T, Lee K, Sanada M, Tsuda M, Ohama K, Tanimoto K, Bollen AM (2005) Relationship between self-reported periodontal status and skeletal bone mineral density in Japanese postmenopausal women. Menopause 12:144–148. https://doi.org/10.1097/00042192-200512020-00007
Blicher B, Joshipura K, Eke P (2005) Validation of self-reported periodontal disease: a systematic review. J Dent Res 84:881–890. https://doi.org/10.1177/154405910508401003
Foster Page LA, Thomson WM, Broadbent JM (2016) Validity of self-reported periodontal questions in a New Zealand cohort. Clin Oral Investig 20:563–569. https://doi.org/10.1007/s00784-015-1526-0
Matsumoto C, Kushida K, Yamazaki K, Imose K, Inoue T (1994) Metacarpal bone mass in normal and osteoporotic Japanese women using computed X-ray densitometry. Calcif Tissue Int 55:324–329. https://doi.org/10.1007/BF00299308
Simpson TC, Weldon JC, Worthington HV, Needleman I, Wild SH, Moles DR, Stevenson B, Furness S, Iheozor-Ejiofor Z (2015) Treatment of periodontal disease for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev 2015:CD004714. https://doi.org/10.1002/14651858.CD004714.pub3
Penoni DC, Vettore MV, Torres SR, Farias MLF, Leão ATT (2019) An investigation of the bidirectional link between osteoporosis and periodontitis. Arch Osteoporos 14:94. https://doi.org/10.1007/s11657-019-0643-9
Iwasaki M, Nakamura K, Yoshihara A, Miyazaki H (2012) Change in bone mineral density and tooth loss in Japanese community-dwelling postmenopausal women: a 5-year cohort study. J Bone Miner Metab 30:447–453. https://doi.org/10.1007/s00774-011-0337-x
Hong SJ, Yang BE, Yoo DM, Kim SJ, Choi HG, Byun SH (2021) Analysis of the relationship between periodontitis and osteoporosis/fractures: a cross-sectional study. BMC Oral Health 21:125. https://doi.org/10.1186/s12903-021-01496-1
Dietrich T, Nunn M, Dawson-Hughes B, Bischoff-Ferrari HA (2005) Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation. Am J Clin Nutr 82:575–580. https://doi.org/10.1093/ajcn.82.3.575
Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari HA (2004) Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr 80:108–113. https://doi.org/10.1093/ajcn/80.1.108
Perić M, Cavalier E, Toma S, Lasserre JF (2018) Serum vitamin D levels and chronic periodontitis in adult, Caucasian population – a systematic review. J Periodontal Res 53:645–656. https://doi.org/10.1111/jre.12560
Nepomuceno R, Pigossi SC, Finoti LS, Orrico SRP, Cirelli JA, Barros SP, Offenbacher S, Scarel-Caminaga RM (2017) Serum lipid levels in patients with periodontal disease: a meta-analysis and meta-regression. J Clin Periodontol 44:1192–1207. https://doi.org/10.1111/jcpe.12792
Lee S, Im A, Burm E, Ha M (2018) Association between periodontitis and blood lipid levels in a Korean population. J Periodontol 89:28–35. https://doi.org/10.1902/jop.2017.170111
Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T, Soen S, Nishizawa Y, Hagino H, Fukunaga M, Fujiwara S (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis – executive summary. Arch Osteoporos 7:3–20. https://doi.org/10.1007/s11657-012-0109-9
Hefti AF (2000) Preshaw PM (2012) Examiner alignment and assessment in clinical periodontal research. Periodontol 59:41–60. https://doi.org/10.1111/j.1600-0757.2011.00436.x
Nijland N, Overtoom F, Gerdes VEA, Verhulst MJL, Su N, Loos BG (2021) External validation of a rapid, non-invasive tool for periodontitis screening in a medical care setting. Clin Oral Investig 25:6661–6669. https://doi.org/10.1007/s00784-021-03952-2
Uemura Y, Sone T, Tanaka S, Miyazaki T, Tsukiyama M, Taguchi A, Soen S, Mori S, Hagino H, Sugimoto T, Fukunaga M, Ohta H, Nakamura T, Orimo H, Shiraki M, Adequate Treatment of Osteoporosis (A-TOP) Research Group (2020) Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04. Curr Med Res Opin 36:1847–1859. https://doi.org/10.1080/03007995.2020.1816537
Hagino H, Sugimoto T, Tanaka S, Sasaki K, Sone T, Nakamura T, Soen S, Mori S (2021) A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05. Osteoporos Int 32:2301–2311. https://doi.org/10.1007/s00198-021-05996-2
Huang YF, Chang CT, Liu SP, Muo CH, Tsai CH, Hong HH, Shen YF, Wu CZ (2016) The impact of oral hygiene maintenance on the association between periodontitis and osteoporosis: a nationwide population-based cross sectional study. Medicine (Baltimore) 95:e2348. https://doi.org/10.1097/MD.0000000000002348
Acknowledgements
The authors would like to thank those who participated as clinical investigators in JOINT-04 and JOINT-05, the members of the central ethics committee, and the members of the data monitoring committee. The authors would like to express their sincere thanks to Dr. Masao Fukunaga, one of the independent evaluators of the X-rays. The authors would also like to express their sincere thanks to Mr. Teruhiko Miyazaki and Ms. Yuko Iwata for their secretarial help. We also thank Helen Jeays, BDSc AE, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.
Funding
This JOINT study was sponsored by the Public Health Research Foundation. This study was also supported in part by funding of the Project Promoting Clinical Trials for Development of New Drugs (19lk0201061t0004) from the AMED to S.T. and partially funded by JSPS KAKENHI grants provided to A.T. (grant number JP18K09758).
Author information
Authors and Affiliations
Consortia
Contributions
Conception and design: A. Taguchi, Y. Uemura, H. Ohta; analysis and interpretation of the data: A. Taguchi, Y. Uemura, S. Tanaka; drafting of the article: A. Taguchi, Y. Uemura, H. Ohta, S. Mori, H. Hagino; critical revision of the article for important intellectual content: M. Shiraki, T. Nakamura, S. Soen; final approval of the article: all the authors.
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The protocol of JOINT-04/JOINT-05 was approved by the Central Ethical Committee for the Adequate Treatment of Osteoporosis (A-TOP) group.
Consent to participate
All patients provided written, informed consent.
Consent for publication
All patients provided written, informed consent.
Conflicts of interest
A. Taguchi has received lecture fees from Asahi Kasei Pharma Corp., Daiichi Sankyo Co. Ltd, Chugai Pharmaceutical Co. Ltd, and Teijin Pharma Ltd. He has received a consultation fee from Media Corp. Ltd. Y. Uemura has received outsourcing fees from Chugai Pharmaceutical Co. S. Tanaka has received lecture fees from Bayer Yakuhin, Amgen Astellas BioPharma K.K., and the Research Institute of Healthcare Data Science. He has received consultation fees and outsourcing fees from Daiichi Sankyo Co. Ltd, Boehringer Ingelheim, Satt, and the Public Health Research Foundation. He has received research grants from the Japan Agency for Medical Research and Development; the Japanese Ministry of Health Labor and Welfare; the Japanese Ministry of Education, Science, and Technology; and Novo Nordisk. He has engaged in a research project for the Japan Agency for Medical Research and Development. H. Hagino has received lecture fees or grants outside the submitted work from Amgen Inc., Asahi Kasei Pharma Corp., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd, Daiichi Sankyo Co. Ltd, Eisai Co. Ltd, Eli Lilly Japan Co. Ltd, Pfizer Japan Inc., Mitsubishi Tanabe Pharma Corp., Mochida Pharma Co. Ltd, Ono Pharmaceutical Co. Ltd, Pfizer Japan Inc., Taisho Pharmaceutical Co. Ltd, Teijin Pharma Ltd, and UCB Japan Co. Ltd. S. Soen has received consulting fees, speaking fees, and/or honoraria from Asahi Kasei Pharma, Astellas, Amgen, Daiichi-Sankyo, Eli Lilly Japan, and UCB Japan. M. Shiraki, H. Ohta, S. Mori, and T. Nakamura declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Taguchi, A., Uemura, Y., Tanaka, S. et al. Influence of symptomatic periodontal disease on changes in skeletal bone density during medication therapy for osteoporosis in postmenopausal women: the Japanese Osteoporosis Intervention Trial (JOINT)-04 and JOINT-05. Arch Osteoporos 17, 7 (2022). https://doi.org/10.1007/s11657-021-01054-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11657-021-01054-w